WhiteOak Capital Pharma and Healthcare Fund-Reg (G) - Portfolio Analysis
- Equity
- Pharma & Healthcare
- Status: Open
Portfolio Overview
As of December 31, 2025
Asset Allocation
Equity: 93.65%Others: 3.75%Debt: 2.60%
Market Cap
Large Cap: 33.26%Small Cap: 40.31%Mid Cap: 20.08%
Number of stocks
50
Top 10 Holdings
110.64% of portfolio
Market Cap of Equity
Large Cap
33.2600%
Small Cap
40.3100%
Mid Cap
20.0800%
Companies Allocation of Equity
SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/-21.82%
JB Chemicals & Pharmaceuticals Limited16.76%
MAX HEALTHCARE INSTITUTE LIMITED EQ13.80%
LAURUS LABS LIMITED EQ NEW FV RS. 2/-10.88%
FORTIS HEALTHCARE LIMITED. EQ10.50%
LUPIN LIMITED EQ NEW F.V. RS.2/-9.58%
DIVIS LABORATORIES LIMITED EQ NEW RS. 2/-9.00%
CIPLA LIMITED EQ NEW FV RS.2/-7.80%
ALKEM LABORATORIES LIMITED EQ5.52%
NEULAND LABORATORIES LIMITED EQ4.98%
Sector Allocation of Equity
Pharmaceuticals & Biotechnology63.82%
Healthcare Services24.53%
Industrial Products2.07%
Chemicals & Petrochemicals2.11%
Healthcare Equipment & Supplies1.12%
SIP Amount
Monthly SIP Date
WhiteOak Capital Pharma and Healthcare Fund-Reg (G)


Is This Mutual Fund Right for You?
+10k investors used our Suitability Test to get better returns
Fund Suitability Test
Let's Get Started.
Frequently Asked Questions
Everything You Need To Know To Get Started With Confidence
In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.